Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Number To Know…0.03

Executive Summary

0.03mm is the width of the robotically controlled surgical needle used in a groundbreaking procedure to remove a blood clot in the eye.

Innovators in surgical robotics are striving to develop devices with ever decreasing dimensions to allow use in the tiniest spaces within the body. In January, Peter Stalmans at Belgium’s University Hospitals Leuven used a surgical robot with a needle of barely 0.03mm wide to slowly inject a thrombolytic drug in the retinal vein of a patient to dissolve a blood clot (causing retinal vein occlusion) – the first procedure of its kind. Until now, it would have been impossible to safely insert a needle into the vein by hand to inject medicine and remove the blood clot.

To find out more about this and other technological advances in surgical robotics, including robotic catheters for atrial fibrillation treatment and origami robots, click here to read Medtech Insight’s latest market intelligence feature.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT104513

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel